Al-Quds Group for Medical Products Wins the Excellence in Digital Transformation Award at Pharmaconex 2026

Cairo - Afaq News - Al-Quds Group for Medical Products won the Excellence in Digital Transformation award at the Pharmaconex Pharma Awards 2026, held alongside the international Pharmaconex conference and exhibition for pharmaceutical industries in Cairo, organized by Informa Markets in collaboration with CPHI Global, during the awards ceremony that took place on September 2.

The group's victory came after competing against more than 100 submissions from various companies in the Middle East, where Al-Quds Group presented its experience in developing and automating several technical processes, quality assurance, and pharmaceutical production, as well as utilizing digital systems, data, modern technologies, and artificial intelligence to enhance efficiency and improve work methods.

The award was received by Mr. Rami Al-Qutub, General Manager of Al-Quds Group for Medical Products, and Dr. Maher Al-Kharouf, Quality Manager at the group.

Al-Qutub stated: "This victory confirms that investing in the development of work systems is an investment in the future of the group. Our vision is to build a more efficient, flexible, and competitive pharmaceutical group, where continuous development, quality, and technology are fundamental pillars for growth and meeting the needs of patients in the markets we serve."

The systems developed by the group focus on automating processes related to quality and manufacturing, maintaining the integrity and reliability of quality data, and enhancing traceability and control, which contributes to strengthening the quality system and improving operational efficiency, in line with the latest requirements and practices of Good Manufacturing Practice (GMP) and global protocols related to data safety.

For her part, Dr. Lina Barakat, Deputy General Manager of the group, said: "We have worked on using digital systems to facilitate work in quality and production, reduce manual procedures, and improve the accuracy and speed of information, while maintaining the integrity of quality data. This development builds on the quality system, certifications, and accreditations that the group's factories possess.",

These systems have been implemented in the group's factories in Palestine, while work is underway to implement them in the group's factories in Jordan and Algeria, as part of a trend to unify and develop work tools and systems and enhance operational efficiency at the group level.

The Jerusalem Group for Pharmaceutical Products was established 57 years ago and today produces more than 350 pharmaceutical products, exporting its products to more than 24 countries around the world, with an industrial presence in Palestine, Jordan, and Algeria. The group has also begun, as part of its plans for regional expansion, to establish a pharmaceutical factory in the Kingdom of Saudi Arabia.

Winning the award comes as part of the Jerusalem Group's vision based on continuous development, enhancing quality, investing in technology and innovation, and developing its industrial capabilities, which enhances its ability to keep pace with global developments in the pharmaceutical industry and meet the needs of patients in the markets in which it operates.